Conference 2022 new - SKN Foundation

Advancing South Asian Cardiovascular Health

An In-Person & Virtual International CE accredited Conference Focusing on South Asian Heart Health

Conference Overview

The international conference brought together the voices of world-renowned experts in the field as well as patients and community members who live with heart disease in an efort to understand how collaborative decision-making can help improve heart health outcomes in South Asians in the United States. South Asians are among the fastest growing ethnic groups in the US, and show high rates of heart disease, as compared to other populations.

South Asians (SA) are among the fastest growing racial/ethnic groups in the US and bear a highly disproportionate burden of cardiovascular disease (CVD). SAs have the highest CVD rates among all racial/ethnic groups in the US, with a significantly higher prevalence of coronary artery disease (CAD), type 2 diabetes, hypertension, and a higher percentage of body fat than other immigrant groups and whites. Also, SAs tend to develop CAD at a younger age, often before 40 in men, and are more likely to die from CAD than other ethnic groups.

SAs in the US have few established resources related to their high risk for CVD, with significant implications for their health and well-being. Poor CVD outcomes management in SAs may be due to a lack of culturally and linguistically appropriate education materials for patients, inadequate patient knowledge of the healthcare system, lack of health insurance, and other social determinants – an area of further research. This diverse population also often faces tremendous cultural, socioeconomic, linguistic, and structural obstacles to achieving good health. Compounding these challenges, there is a dearth of detailed data on the unique risks, etiologic mechanisms, and effective interventions for CVD in first- and second-generation SAs in the US. This can lead to sub-optimal management of CVD, its risk factor modification, and thus increased recurrent CAD events, exacerbating racial/ethnic disparities and increasing the economic burden of CVD in the US.

In order to begin reversing this knowledge deficit, providers, patients, and shareholders need to be able to 1) identify risk factors, including social determinants, 2) learn about CVD management from worldwide programs, 3) understand the value of research participation in establishing priorities for future work on managing CVD in SAs in the US.

This international conference on South Asian cardiovascular health was designed to provide a high-quality scientific forum in a collaborative environment, which included patients and providers. Internationally renowned researchers and clinicians lead sessions addressing
CVD risk factors, barriers to management, the role of Big Data, community prevention strategies, and the state of South Asian cardiovascular health in the United States from the AHA, ADA, and NIH perspectives.

Goals & Objectives
  • Improve identification of risk factors, including social determinants, of cardiovascular disease in South Asians to create a framework for strategies for prevention, early diagnosis, and targeted treatment
  • Exchange information from worldwide programs to understand and enhance cardiovascular disease management and post-acute care in South Asians
  • Establish a list of priorities for future work on managing cardiovascular disease in South Asians

Target Audience
This activity is designed for healthcare professionals, trainees, and students involved with or interested in the healthcare of South Asians. In addition, this activity will be beneficial for patients, families/caretakers, community leaders and members, and social institutions so they can learn how they can assist with promoting optimal health for this diverse population.

CE Accreditation

In support of improving patient care, this activity has been planned and implemented by Rutgers Biomedical and Health Sciences, SKN Foundation, Eastern Virginia Medical School and Saint Peter’s University Hospital. Rutgers Biomedical and Health Sciences is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians: Rutgers Biomedical and Health Sciences designates this live activity for a maximum of 10.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses: This activity is awarded 10.25 ANCC contact hours. Nurses should claim only those contact hours actually spent participating in the activity.

Physician Assistants: NCCPA accepts certificates of participation for educational activities approved for AMA PRA Category 1 Credit™ from organizations accredited by ACCME.

Method of Participation
In order to meet the learning objectives and receive continuing education credits, participants are expected to formally register for the symposium, check in at the registration desk and attend the program each day (in-person)/watch the webcast, and complete an online evaluation at the conclusion of the program. A CE certificate will be emailed to participants upon completion of the online evaluation.

Keynote Speaker

Salim Yusuf, D.Phil, FRCPC, FRSC, O.C

Heart and Stroke Foundation/Marion W. Burke Chair in Cardiovascular Disease

Distinguished University Professor of Medicine, McMaster University, Ontario, Canada

Click here for to see the Conference Video

Raj Bhopal, CBE, DSc (hon), MD, BSc, MBChB, MPH, FRCP(E), FFPH

Emeritus Professor of Public Health Edinburgh Migration, Ethnicity and Health Research Group, Usher Institute, Medical School, University of Edinburgh

Click here for to see the Conference Video

SPECIAL GUEST SPEAKERS

Guillermo Umpierrez

MD, CDCES, FACE, MACP

President, Medicine & Science, American Diabetes Association

Professor of Medicine, Emory University School of Medicine;

Division of Endocrinology, Metabolism,

Chief of Diabetes and Endocrinology, Grady Health Systems,

Emory University School of Medicine, GA

Click here for to see the Conference Video

Donald Lloyd-Jones

MD, ScM, FACC, FAHA

President, American Heart Association

Chair, Department of Preventive Medicine.

Eileen M. Foell Professor. Professor of Preventive Medicine

(Epidemiology), Medicine (Cardiology) and Pediatrics,

Northwestern University Feinberg School of Medicine, IL

Click here for to see the Conference Video

CONFERENCE SPEAKERS

Arun Chockalingam

MS, PhD, FACC, FAHA

Professor of Medicine and Global Health, University of Toronto

Professor and Advisor to the Dean on Global Health, Faculty of Health, York University, Toronto, Canada

Founding Director, Office of Global Health, NHLBI, NIH

Click here for to see the Conference Video

Yuling Hong

MD, MSc, PhD, FAHA

Chief, Epidemiology Branch

Division of Cardiovascular Sciences

NHLBI, NIH

Click here for to see the Conference Video

Alka Kanaya

MD

Professor of Medicine, Epidemiology and Biostatistics, Division of General Internal Medicine, University of California, San Francisco (UCSF), CA

Co-Leader, Mediators of Atherosclerosis in South Asians Living in America (MASALA) Study

Click here for to see the Conference Video

Ashish Mathur

B.Tech, MS

Co- Founder & Executive Director, South Asian Heart Center, El Camino Hospital, Mountain View, CA

Click here for to see the Conference Video

V. Mohan

MD, FRCP (London, Edinburgh, Glasgow & Ireland), PhD, DSc, D.c (Hon. Causa), FNASc, FASc, FNA, FACE, FACP, FTWAS, MACP, FRS (Edinburgh)

Chairman, Dr. Mohan’s Diabetes Specialities Centre of Excellence in Diabetes Care, Southern India President and Director, Madras Diabetes Research Foundation, Chennai, India

Click here for to see the Conference Video

Latha Palaniappan

MD, MS

Professor of Medicine (Primary Care and Population Health), Stanford University School of Medicine, CA

Scientific Director, Precision Genomics and Pharmacogenomics in Primary Care, Stanford Division of Primary Care and Population Health

Faculty Co-Director, Stanford Biobank

Co-Founder and Co-Director, Center for Asian Health Research and Education (CARE), Stanford Medicine

Click here for to see the Conference Video

Daniel J. Rader

M.D., FAHA

Chief, Division of Translational Medicine and Human Genetics

Associate Director, Institute for Translational Medicine and Therapeutics

Director, Preventive Cardiovascular Program

Seymour Gray Professor of Molecular Medicine, Perelman School of Medicine, University of Pennsylvania, PA

Click here for to see the Conference Video

Salim Virani

MD, PhD, FACC, FAHA, FASPC

Professor in Cardiology and Cardiovascular Research

Director, Cardiovascular Disease Fellowship Training Program, Baylor College of Medicine, Houston, TX

Co-Director, VA Advanced Fellowship Program in Health Services Research & Development

Click here for to see the Conference Video

CONFERENCE LEADERSHIP TEAM

Sunita Dodani MBBS (MD), FCPS, MSc, PhD, FAHA

Professor of Medicine, Department of Internal Medicine & Professor, School of Health Professions (SHP)

Eastern Virginia Medical School (EVMS), & Founding Director, EVMS-Sentara Healthcare Analytics and Delivery Science Institute (HADSI)

Founder and Chair, Health Equity Collaborative of Virginia

Board Member, American Heart Association- National Research Committee

Board Director, American Heart Association- Hampton Roads Chapter

Naveen Mehrotra, MD, MPH

Director, My Whole Child Pediatrics

Founder and Executive Director, SKN Foundation

Clinical Assistant Professor of Pediatrics, Rutgers-RWJ Medical School

Adjunct Assistant Professor, Rutgers-RWJ School of Public Health

Meena S. Murthy, MD, FACE

Chief, Division of Endocrinology, Nutrition and Metabolism

Director, Thyroid and Diabetes Center

Director, South Asian Institute and SKN South Asian Diabetes Center

Saint Peter’s University Hospital, New Brunswick, NJ

Click here for to see the Conference Video

Collaborating Organization

About the Medical Society of New Jersey:

Founded in 1766, the Medical Society of New Jersey (MSNJ) is the oldest professional society in the United States. MSNJ has a mission to promote the betterment of the public health and the science and the art of medicine, to enlighten public opinion in regard to the problems of medicine, and to safeguard the rights of the practitioners of medicine. MSNJ represents all medical disciplines and serves as an advocate for patient and physician rights. Its members are dedicated to ensuring delivery of the highest quality medical care throughout New Jersey. For more information, visit www.msnj.org.